About CymoGen Dx
CymoGen Dx is a company based in New Windsor (United States) founded in 2010 was acquired by Biocare Medical in October 2014.. CymoGen Dx has raised $350.16 thousand across 1 funding round from investors including Biocare Medical. CymoGen Dx offers products and services including FISH Probes, Primary Antibodies, and Detection Systems. CymoGen Dx operates in a competitive market with competitors including Guardant Health, Abcam, Foundation Medicine, ArcherDX and Natera, among others.
- Headquarter New Windsor, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biocare Medical, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$350.16 K (USD)
in 1 rounds
-
Latest Funding Round
$350.16 K (USD), Seed
Jul 06, 2010
- Investors
-
Employee Count
Employee Count
-
Acquired by
Biocare Medical
(Oct 03, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CymoGen Dx
CymoGen Dx offers a comprehensive portfolio of products and services, including FISH Probes, Primary Antibodies, and Detection Systems. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Tools for detecting genomic changes in cancer tissues
Reagents for tissue staining and analysis
Kits for fluorescence and hybridization processes
Funding Insights of CymoGen Dx
CymoGen Dx has successfully raised a total of $350.16K through 1 strategic funding round. The most recent funding activity was a Seed round of $350.16 thousand completed in July 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $350,161
-
First Round
First Round
(06 Jul 2010)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2010 | Amount | Seed - CymoGen Dx | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CymoGen Dx
CymoGen Dx has secured backing from 1 investor. Prominent investors backing the company include Biocare Medical. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CymoGen Dx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CymoGen Dx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cymogen Dx Comparisons
Competitors of CymoGen Dx
CymoGen Dx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Abcam, Foundation Medicine, ArcherDX and Natera, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Biological reagents and antibodies are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomic technologies and drug discovery platforms are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about CymoGen Dx
When was CymoGen Dx founded?
CymoGen Dx was founded in 2010.
Where is CymoGen Dx located?
CymoGen Dx is headquartered in New Windsor, United States. It is registered at New Windsor, New York, United States.
Is CymoGen Dx a funded company?
CymoGen Dx is a funded company, having raised a total of $350.16K across 1 funding round to date. The company's 1st funding round was a Seed of $350.16K, raised on Jul 06, 2010.
What does CymoGen Dx do?
CymoGen Dx was founded in 2010 in New Windsor, United States, within the biotechnology sector focused on genomics. Next-Gen FISH probes are produced to detect chromosomal aberrations in FFPE tissues, bone marrow, aspirates, and blood samples, aiding research on hematologic and solid tumor cancers. A GMP-compliant fluorescent labeling system is also provided for these applications. Operations center on reagent development for diagnostic and study purposes.
Who are the top competitors of CymoGen Dx?
CymoGen Dx's top competitors include Guardant Health, Abcam and Strand Life Sciences.
What products or services does CymoGen Dx offer?
CymoGen Dx offers FISH Probes, Primary Antibodies, and Detection Systems.
Who are CymoGen Dx's investors?
CymoGen Dx has 1 investor. Key investors include Biocare Medical.